Verona Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	1,198	1,589	1,976	403	302	76	127	152
Market Cap Growth	-	-19.58%	390.00%	33.66%	298.54%	-40.24%	-16.92%	-
Enterprise Value	978	1,369	1,759	261	120	36	22	51
PE Ratio	-29.23	-29.23	-28.76	-7.26	-4.63	-1.87	-5.01	-5.86
PS Ratio	-	-	4314.45	10.08	-	-	-	-
PB Ratio	4.81	6.38	8.57	2.73	1.63	1.77	1.23	1.50
P/FCF Ratio	-31.64	-31.64	-32.99	-12.12	-6.68	-1.76	-4.39	-5.58
P/OCF Ratio	-31.64	-31.64	-33.01	-12.13	-6.69	-1.77	-4.39	-5.58
EV/Sales Ratio	-	-	3840.26	6.52	-	-	-	-
EV/EBITDA Ratio	-26.75	-26.75	-26.14	-4.77	-1.86	-0.90	-0.77	-1.75
EV/EBIT Ratio	-26.40	-26.40	-25.89	-4.72	-1.84	-0.89	-0.77	-1.75
EV/FCF Ratio	-27.25	-27.25	-29.37	-7.84	-2.65	-0.84	-0.78	-1.85
Debt / Equity Ratio	0.21	0.21	0.05	0.04	0.03	0.03	0.01	-
Debt / EBITDA Ratio	-1.00	-1.00	-0.16	-0.11	-0.09	-0.03	-0.02	-
Debt / FCF Ratio	-1.02	-1.02	-0.18	-0.17	-0.13	-0.03	-0.02	-
Quick Ratio	31.27	31.27	11.97	4.44	13.24	3.18	6.35	9.55
Current Ratio	33.33	33.33	12.77	5.09	14.26	4.23	6.78	10.13
Asset Turnover	0	0	0.00	0.20	0	0	0	0
Interest Coverage	-25.20	-25.20	-130.38	-162.49	-1856.14	-	-17.21	-9.22
Return on Equity (ROE)	-20.50%	-20.50%	-39.00%	-34.60%	-52.80%	-70.20%	-28.60%	-35.80%
Return on Assets (ROA)	-17.70%	-17.70%	-32.00%	-27.90%	-41.50%	-56.80%	-23.70%	-30.20%
Return on Capital (ROIC)	-22.48%	-22.48%	-31.42%	-47.66%	-38.93%	-119.09%	-31.46%	-37.25%
Earnings Yield	-4.54%	-3.42%	-3.48%	-13.78%	-21.59%	-53.58%	-19.95%	-17.07%
FCF Yield	-4.19%	-3.16%	-3.03%	-8.25%	-14.97%	-56.70%	-22.77%	-17.92%
Buyback Yield / Dilution	-19.86%	-19.86%	-10.20%	-39.23%	-227.37%	-0.29%	-2.20%	-
Total Shareholder Return	-19.86%	-19.86%	-10.20%	-39.23%	-227.37%	-0.29%	-2.20%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).